PT-141 dosage in mg ranges from the FDA-approved 1.75 mg to 1–2 mg used off-label. See how mg converts to ml and units, plus safety and storage basics.
PT-141 (bremelanotide) is dosed in milligrams, and the FDA-approved dose is 1.75 mg injected under the skin once per day. That dose cannot be repeated within 24 hours, and the label limits use to no more than 8 doses per month. Doses used in off-label or research settings usually fall between 1 mg and 2 mg, but those doses are not FDA-approved for anyone.
What PT-141 Is and Why the Dose Matters
PT-141 is a synthetic peptide that activates melanocortin receptors in the brain rather than increasing blood flow directly. The FDA approved it in 2019 as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women. It is given by subcutaneous injection, usually into the abdomen or thigh.
Because PT-141 works on the central nervous system, dose and timing matter more than they do with many other sexual health medications. Taking too much raises the risk of nausea, flushing, and blood pressure changes without improving results. Many people who search for pt-141 dosage are really looking for a clear starting point, and the honest answer is that the FDA label gives one for premenopausal women and no approved dose exists for men.
PT-141 Dosage in mg: Approved vs. Research Use
The table below compares the FDA-approved dose with doses described in off-label and research settings. These numbers are for reference only and are not a recommendation.
| Use case | Typical dose | Frequency | Status |
|---|---|---|---|
| Premenopausal women with HSDD | 1.75 mg | Once per day, not more than once in 24 hours, max 8 doses per month | FDA-approved (Vyleesi) |
| Off-label use in men | 1–2 mg | Single dose as needed | Not FDA-approved for men |
| Higher research doses | 2 mg and above | Not established | Not recommended; more side effects |
No approved male dose exists because the manufacturer never received FDA clearance to market the drug to men. Men who use it do so off-label, typically at 1 mg to 2 mg.
For premenopausal women, the label is strict: 1.75 mg, once, and not again for at least 24 hours. The 8-dose monthly cap exists because repeated use has been linked to focal hyperpigmentation and temporary blood pressure increases.
Converting mg to ml and Syringe Units
Most research vials are sold as lyophilized powder that must be reconstituted with bacteriostatic water. The concentration you create determines how many milliliters or syringe units equal a milligram. This is where most confusion about pt-141 dosage in ml comes from.
| Vial size | Water added | Concentration | 1 mg equals | 1.75 mg equals |
|---|---|---|---|---|
| 10 mg | 1 mL | 10 mg/mL | 0.1 mL (10 units) | 0.175 mL (17.5 units) |
| 10 mg | 2 mL | 5 mg/mL | 0.2 mL (20 units) | 0.35 mL (35 units) |
| 5 mg | 1 mL | 5 mg/mL | 0.2 mL (20 units) | Not applicable |
"Units" here means units on a U-100 insulin syringe, where 100 units equal 1 mL. A common question is pt-141 10mg dosage in units; with 1 mL of water, 1 mg is 10 units and 1.75 mg is 17.5 units.
Always double-check the math before injecting, and never assume two vials are mixed the same way. If the concentration is wrong, the dose is wrong.
Women vs. Men: How the Dose Differs
The only FDA-approved pt-141 dosage for women is 1.75 mg, delivered as a fixed-dose auto-injector. There is no weight-based adjustment and no titration step in the label.
For men, there is no approved dose at all. Reports from off-label use describe single doses of 1 mg to 2 mg, sometimes labeled as pt-141 peptide dosage for men, but no large clinical trial supports those numbers. Men should not assume the 1.75 mg female dose transfers directly.
One practical point: PT-141 is not a daily drug for most users. It is taken shortly before anticipated sexual activity, and the effect can last for several hours.
Timing, Duration, and Storage
PT-141 reaches peak blood levels in about one hour, and users typically inject 30 to 60 minutes before activity. Nausea is the most common side effect, and it tends to be worse when the dose is taken on an empty stomach.
Reconstituted peptide should be kept refrigerated. A frequent question is how long does pt-141 last in fridge; most vendors and compounding guides suggest about 30 days for a reconstituted vial, though some sources stretch that to 6 weeks. Lyophilized powder stored dry and cold lasts much longer.
Do not freeze reconstituted PT-141, and keep it out of direct light. If the solution looks cloudy or contains particles, discard it.
Safety and Legal Considerations
PT-141 is a prescription drug in the United States. Buying it online without a prescription is illegal, and research-grade vials are labeled "not for human consumption."
Common side effects include nausea, flushing, headache, and injection-site reactions. PT-141 can raise blood pressure and may darken the gums or skin with repeated use. People with uncontrolled high blood pressure or cardiovascular disease should avoid it unless a doctor says otherwise.
This article is for information only and is not medical advice. Talk to a healthcare professional before using PT-141, especially if you take blood pressure medication or have a history of heart problems.
Frequently Asked Questions
What is the standard PT-141 dosage in mg?
The FDA-approved dose is 1.75 mg injected subcutaneously, once per day, with no repeat dose within 24 hours and no more than 8 doses per month. That approval applies to premenopausal women with hypoactive sexual desire disorder. No FDA-approved dose exists for men, and off-label reports usually describe 1 mg to 2 mg.
How many units is 1 mg of PT-141?
It depends on how the vial is reconstituted. A 10 mg vial mixed with 1 mL of bacteriostatic water gives a concentration of 10 mg/mL, so 1 mg equals 0.1 mL or 10 units on a U-100 insulin syringe. Mixing the same 10 mg vial with 2 mL of water doubles the volume, so 1 mg equals 0.2 mL or 20 units.
Can men use PT-141?
PT-141 is not FDA-approved for men, so any male use is off-label and at a doctor's discretion. Reports describe single doses of 1 mg to 2 mg, but those numbers come from small studies and informal use, not a regulated label. Men should discuss risks, including blood pressure changes and nausea, with a healthcare professional first.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.